Description:
ULLRICH CONGENITAL MUSCULAR DYSTROPHY; UCMD1
COLLAGEN, TYPE VI, ALPHA-1; COL6A1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Muscular Dystrophies CMD Specific PIGI Consented Sample |
Protocols |
Protocol PDF |
Biopsy Source
|
Blood
|
Cell Type
|
Stem cell
|
Cell Subtype
|
Induced pluripotent stem cell
|
Transformant
|
Reprogrammed (Sendai)
|
Sample Source
|
iPSC from Blood
|
Race
|
White
|
Ethnicity
|
Australian
|
Country of Origin
|
AUSTRALIA
|
Family Member
|
1
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
ISCN
|
46,XY[19]
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
18 |
|
Induced Pluripotent Stem Cell |
The frozen cell line submitted to the Repository was recovered and expanded. The expanded line was evaluated for viability surface antigen expression and alkaline phosphatase activity. Pluripotency was assessed via embryoid body (EB) formation. Steady-state mRNA expression patterns of undifferentiated iPSC and EBs were determined via real-time PCR. Characterization data are included in the Certificate of Analysis. |
|
Gene |
COL6A1 |
Chromosomal Location |
21q22.3 |
Allelic Variant 1 |
; |
Identified Mutation |
del exons 5-9 |
Remarks |
Clinically affected; diagnosis confirmed via creatine kinase level, muscle biopsy, and electromyography; hypermobility; scoliosis; tortocolis; trigger thumb; low muscle tone; various contractures; motor functions achieved and maintained without assistance. Researchers purchasing hiPSCs from the NIGMS Repository are responsible for any limited use label licenses (LULLs) applicable to the cell line purchased. The applicable LULL to this line is Sendai-CytoTune. |
Passage Frozen |
18 |
Split Ratio |
1:20 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
mTeSR1 |
Serum |
0% none |
Substrate |
Matrigel |
Supplement |
- |
|
|